✦ LIBER ✦

Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone

✍ Scribed by Chang, Hong; Jiang, Allan; Qi, Connie; Trieu, Young; Chen, Christine; Reece, Donna

Book ID: 121466112
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 767 KB
Volume: 51
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2010.524325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Lenalidomide and Dexamethason

Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone

✍ Jesús F. San-Miguel; Meletios A. Dimopoulos; Edward A. Stadtmauer; S. Vincent Ra 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 208 KB

Impact of high-risk cytogenetics and pri

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

✍ Avet-Loiseau, H; Soulier, J; Fermand, J-P; Yakoub-Agha, I; Attal, M; Hulin, C; G 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 313 KB

Treatment of patients with relapsed/refr

Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies

✍ Dimopoulos, M A; Kastritis, E; Christoulas, D; Migkou, M; Gavriatopoulou, M; Gko 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 473 KB

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

Impact of prior therapies on the relativ

Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma

✍ Dan T. Vogl; Edward A. Stadtmauer; Paul G. Richardson; Pieter Sonneveld; Michael 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Impact on response and survival of DNA r

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide

✍ María Teresa Cibeira; Carlos Fernández de Larrea; Alfons Navarro; Tania Díaz; Do 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 332 KB